Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Physio-Control

This article was originally published in The Gray Sheet

Executive Summary

Conducting field correction recall of all LifePak 10 external defibrillator/monitors because of device problems including premature wear of the product's coil cords. In some high- usage situations, the cords have worn out in two-to-three years instead of the expected five. The first replacements will take place on older devices. Currently manufactured devices continue to be shipped with the older coils due to insufficient quantities of new coils. The recall follows the May reintroduction of the LifePak 10, the only device Physio-Control has resumed marketing since it shut down operations a year ago because of regulatory problems ("The Gray Sheet" May 24, I&W-4). Physio-Control says it anticipated the LifePak 10 recall when it resumed marketing and that FDA was aware of the situation.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000986

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel